Implementation Guide CH VACD
4.0.1 - trial-use Switzerland flag

This page is part of the CH VACD (R4) (v4.0.1: STU 4) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example Bundle: Test Case A 01: Patient Dokument (A-D1-P_C1)

Immunization Administration

Id: A-D1-P-C1-Composition

Identifier: urn:ietf:rfc:3986#urn:uuid:b505b90a-f241-41ca-859a-b55a6103e753

Status: Final

Code: Immunization record (

Patient: Patient/TC-patient Wegmueller Monika

Date: June 1, 2021


Patient/TC-patient Wegmueller Monika

Confidentiality: null Normal (qualifier value) (


Immunization Administration

Immunization Administration

Code: Hx of Immunization (



Additional Document Content

2. (Patient/TC-patient)

Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number: 12345678)

3. (Practitioner/TC-HCP1-C1)

Generated Narrative: Practitioner

Resource Practitioner "TC-HCP1-C1"

Profile: CH Core Practitioner EPR

identifier: id: 7601888888884

active: true

name: Peter Müller

telecom: ph: tel:+, fax: fax:+,,

address: Grabenstrasse 2 Zürich 8005 CH

4. (Organization/TC-ORG1)

Generated Narrative: Organization

Resource Organization "TC-ORG1"

Profile: CH Core Organization EPR

identifier: id: 7601777777718

name: Gruppenpraxis Müller


*ph: tel:+, fax: fax:+,, http://www.gruppenpraxis.chGrabenstrasse 2 Zürich ZH 8005 CH

5. (PractitionerRole/TC-HCP1-ORG1-ROLE-performer)

Generated Narrative: PractitionerRole

Resource PractitionerRole "TC-HCP1-ORG1-ROLE-performer"

Profile: CH Core PractitionerRole EPR

active: true

practitioner: See above (Practitioner/TC-HCP1-C1)

organization: See above (Organization/TC-ORG1)

6. (Immunization/TCA01-IMMUN1-patient)

Generated Narrative: Immunization

Resource Immunization "TCA01-IMMUN1-patient"

Profile: CH VACD Immunization

Author of the content: See above (Patient/TC-patient)

CH VACD Extension Immunization Medication Reference: See above (Medication/TC-IMMUN-MEDIC-HAVRIX1440)

identifier: id: acc1f090-5e0c-45ae-b283-521d57c3aa2f


vaccineCode: Havrix 1440 (Swiss Medic Authorized Vaccines Codesystem#558)

lotNumber: AHAVB946A

patient: See above (Patient/TC-patient)

occurrence: 2021-06-01

route: Intramuscular use (


*See above (PractitionerRole/TC-HCP1-ORG1-ROLE-performer)

note: Der Patient hat diese Impfung ohne jegliche Nebenwirkungen gut vertragen. (By Practitioner/TC-HCP1-C1 @2021-06-01)


*Viral hepatitis, type A (disorder) (SNOMED CT#40468003)

7. (Medication/TC-IMMUN-MEDIC-HAVRIX1440)

Generated Narrative: Medication

Resource Medication "TC-IMMUN-MEDIC-HAVRIX1440"

Profile: CH VACD Medication For Immunization

identifier: id: 359000dc-2cee-4a6e-ab05-577f558840e2

code: HAVRIX 1440 Inj Susp (unknown#7680005580054)

status: ACTIVE




8. (Organization/TC-ORG-GSK)

Generated Narrative: Organization

Resource Organization "TC-ORG-GSK"

Profile: CH Core Organization

identifier: id: 7601001000674

name: GlaxoSmithKline AG


*ph: tel:+41 31 862 21 11(WORK), fax: fax:+41 31 862 22 00(WORK),, https://www.gsk.comTalstrasse 3-5 Münchenbuchsee BE 3053 CH